5
Total deals
$124.0M
Total value
$124.0M
Avg deal
$124.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Cend Therapeutics Inc.
A clinical-stage oncology biotech developing targeted anticancer drug delivery t…
|
2022-04-27 | Merge | Complete | — | Deal → |
| 2 |
California Stem Cell
California Stem Cell focuses on manufacturing high-purity human cells for therap…
|
2014-04-15 | Acquisition | Complete | $124.0M | Deal → |
| 3 |
Amorcyte
Amorcyte is a biotechnology company developing cell therapy products to treat ca…
|
2011-07-14 | Acquisition | Complete | — | Deal → |
| 4 |
PCT Cell Therapy Services
PCT provides contract development and manufacturing services for cell therapy pr…
|
2011-01-20 | Acquisition | Complete | — | Deal → |
| 5 |
P
Progenitor Cell Therapy
Progenitor Cell Therapy provides contract development and manufacturing services…
|
2011-01-19 | Acquisition | Complete | — | Deal → |